I

Integrum AB
STO:INTEG B

Watchlist Manager
Integrum AB
STO:INTEG B
Watchlist
Price: 9.47 SEK -2.97% Market Closed
Market Cap: kr246.5m

Relative Value

The Relative Value of one INTEG B stock under the Base Case scenario is 20.65 SEK. Compared to the current market price of 9.47 SEK, Integrum AB is Undervalued by 54%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

INTEG B Relative Value
Base Case
20.65 SEK
Undervaluation 54%
Relative Value
Price
I
Worst Case
Base Case
Best Case

Multiples Across Competitors

INTEG B Competitors Multiples
Integrum AB Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
Integrum AB
STO:INTEG B
246.5m SEK 2.5 -8.3 -5.3 -5.3
US
Abbott Laboratories
NYSE:ABT
188.9B USD 4.3 28.9 16.4 22.4
US
Intuitive Surgical Inc
NASDAQ:ISRG
172B USD 17.1 60.1 45.8 55.4
US
Stryker Corp
NYSE:SYK
138.8B USD 5.5 42.8 21.7 26.3
IE
Medtronic PLC
NYSE:MDT
131.1B USD 3.8 27.5 15.4 22.3
US
Boston Scientific Corp
NYSE:BSX
114.7B USD 5.9 40.9 24.3 33.1
US
Becton Dickinson and Co
NYSE:BDX
59.5B USD 2.7 35.6 13 22.1
DE
Siemens Healthineers AG
XETRA:SHL
47.2B EUR 2.1 22.6 12.7 18
US
IDEXX Laboratories Inc
NASDAQ:IDXX
51.7B USD 12.3 49.9 35.9 39.8
US
Edwards Lifesciences Corp
NYSE:EW
46.7B USD 7.9 34.1 24.2 26.6
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
37.8B USD 1.9 17.1 12.7 15.4
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
SE
I
Integrum AB
STO:INTEG B
Average EV/EBITDA: 22.2
Negative Multiple: -5.3
N/A N/A
US
Abbott Laboratories
NYSE:ABT
16.4
9%
1.8
US
Intuitive Surgical Inc
NASDAQ:ISRG
45.8
24%
1.9
US
Stryker Corp
NYSE:SYK
21.7
12%
1.8
IE
Medtronic PLC
NYSE:MDT
15.4
8%
1.9
US
Boston Scientific Corp
NYSE:BSX
24.3
22%
1.1
US
Becton Dickinson and Co
NYSE:BDX
13
8%
1.6
DE
Siemens Healthineers AG
XETRA:SHL
12.7
11%
1.2
US
IDEXX Laboratories Inc
NASDAQ:IDXX
35.9
14%
2.6
US
Edwards Lifesciences Corp
NYSE:EW
24.2
13%
1.9
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
12.7
10%
1.3